Aldeyra Therapeutics, Inc.
ALDX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001341235
No open-market purchases or sales by Aldeyra Therapeutics, Inc. insiders were filed in the last 90 days; 107 institutions reported holding it in 13F filings for Q2 2026, worth $77.7M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Aldeyra Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- +2 vs. Q1 2024
- Shares held
- 35.3M
- −78.6K (−0.2%) vs. Q1 2024
- Total value
- $116.9M
- +$1.10M (+1.0%) vs. Q1 2024
- New holders
- 18
- 34 more added
- Sold out
- 16
- 32 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 107 | $77.7M |
| Q1 2026 | 128 | $63.3M |
| Q4 2025 | 136 | $201.8M |
| Q3 2025 | 131 | $204.2M |
| Q2 2025 | 122 | $130.8M |
| Q1 2025 | 126 | $215.5M |
| Q4 2024 | 119 | $185.6M |
| Q3 2024 | 112 | $196.4M |
| Q2 2024 | 103 | $116.9M |
| Q1 2024 | 101 | $115.8M |
| Q4 2023 | 105 | $123.3M |
| Q3 2023 | 120 | $252.3M |
| Q2 2023 | 119 | $327.5M |
| Q1 2023 | 109 | $353.4M |
| Q4 2022 | 96 | $237.9M |
| Q3 2022 | 89 | $197.4M |
| Q2 2022 | 95 | $147.5M |
| Q1 2022 | 111 | $171.8M |
| Q4 2021 | 115 | $146.7M |
| Q3 2021 | 117 | $348.9M |
| Q2 2021 | 136 | $512.8M |
| Q1 2021 | 108 | $376.7M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Aldeyra Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Institutional & Family Asset Management, LLC | 50 | $166 | 0.00% | 00.0% | Unchanged |
| Innealta Capital, LLC | 46 | $152 | 0.00% | +46 | New |
| The PNC Financial Services Group, Inc. | 34 | $113 | 0.00% | +34 | New |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −126,176−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −107,748−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −61,601−100.0% | Sold out |
| Denali Advisors LLC | 0 | $0 | 0.00% | −47,300−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −38,193−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −22,952−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −19,664−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −15,670−100.0% | Sold out |
| Kingswood Wealth Advisors, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −11,356−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −10,686−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −4,760−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −544−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −265−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −197−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |